We next confirmed the functional roles of AMPK/mTOR signaling in FATP5-mediated suppression of HCC cell migration and invasion using a specific AMPK inhibitor, Compound C, and an mTOR activator, MHY1485. The gene discussed is SLC27A5; the disease is hepatocellular carcinoma.